IDPC summarises key wins and progress achieved between April 2022 and March 2023 toward ensuring that social justice and human rights are core tenets of drug policies.
IDPC draws on wide-ranging data from UN, government, academic and civil society sources to conclude that there has been little, incomplete or no progress in achieving the goals set out in the 2019 Ministerial Declaration on Drugs.
The Forum addressed development, public health, human rights, and emerging trends in drug policies, with recommendations on decriminalisation, human rights and building support for change.
The Working Group on Women, Drug Policy and Incarceration reflects on almost ten years of collective research and joint advocacy, achievements and disappointments, as well as challenges and opportunities for the future.
IDPC lays out the main challenges and opportunities offered by the upcoming 2024 mid-term review, underscoring that the objectives set out in 2019 have not been met and that a new approach is urgently needed.
IDPC highlights the major gains from the 2023 OHCHR report on human rights and drug policy, and provides recommendations to Member States and UN entities for its effective implementation.
IDPC notes clashes between reform and status quo advocates in the international community, in the context of tensions related to the ongoing invasion of Ukraine by Russia and increasingly central calls for systemic change.
IDPC, Amnesty International, CDPE, HRI, DPA, Release and CELS provide evidence on the role of drug policies as a driver of discriminatory policing and incarceration.
IDPC and ICEERS argue that the right of Indigenous Peoples to grow, use, possess, heal, and travel with their ancestral plants should be enshrined as a part of a right to health free from racial discrimination.
IDPC welcomes the Board's increasing focus on human rights issues and cannabis regulation, whilst regretting its misrepresentation of the evidence on the latter, flawed interpretations of the relationship between human rights and drug control treaties, and a lack of constructive thinking on how to address the proliferation of systemic breaches in the global drug control regime.
IDPC, CDPE, Instituto RIA, HRI and the Health[e]Foundation provide data and recommendations on the importance of decriminalisation to fulfil the human rights of people who use drugs.
IDPC calls on the UN system and Member States to initiate a process to evaluate the human rights impacts of the global drug control regime, and to propose concrete steps for its reform and modernisation.